Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D5OG
|
||||
Former ID |
DNC013692
|
||||
Drug Name |
Kazinol C
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C30H40O4
|
||||
Canonical SMILES |
CC(=CCC1=C(C(=C(C=C1CCCC2=CC(=C(C=C2O)O)C(C)(C)C=C)O)O)<br />CC=C(C)C)C
|
||||
InChI |
1S/C30H40O4/c1-8-30(6,7)25-16-22(26(31)18-27(25)32)11-9-10-21-17-28(33)29(34)24(15-13-20(4)5)23(21)14-12-19(2)3/h8,12-13,16-18,31-34H,1,9-11,14-15H2,2-7H3
|
||||
InChIKey |
YCJJCTRPAGXWGX-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Tyrosine oxidase | Target Info | Inhibitor | [1] | |
BioCyc Pathway | (S)-reticuline biosynthesis | ||||
Eumelanin biosynthesis | |||||
L-dopachrome biosynthesis | |||||
KEGG Pathway | Tyrosine metabolism | ||||
Riboflavin metabolism | |||||
Metabolic pathways | |||||
Melanogenesis | |||||
PathWhiz Pathway | Riboflavin Metabolism | ||||
Tyrosine Metabolism | |||||
WikiPathways | Dopamine metabolism | ||||
References | |||||
REF 1 | Bioorg Med Chem. 2009 Jan 1;17(1):35-41. Epub 2008 Nov 18.Tyrosinase inhibitory effects of 1,3-diphenylpropanes from Broussonetia kazinoki. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.